Partnership Between the Philas Foundation and the Swiss Cancer Institute

The Swiss Cancer Institute (SCI) and the Philas Foundation are forming a partnership to advance the field of gender-specific medicine in oncology over the long term. Together, we aim to help ensure that gender-specific differences are given greater consideration in research and care, thereby promoting more personalized treatment for cancer patients.

The Philas Foundation is committed to individualized medical care and supports projects in the field of gender-sensitive medicine. Its efforts focus in particular on strengthening research, promoting professional education, and raising awareness of the importance of gender-specific differences in medicine.

Gender medicine is not limited to women's health. It examines the differences and similarities between the sexes and their impact on health, disease, diagnosis, and treatment. Such differences can also play an important role in oncology.

For the Swiss Cancer Institute, taking these factors into account is a key component of an increasingly personalized and precision-based approach to cancer care. The goal is to incorporate findings on gender-specific differences more fully into research and clinical practice, thereby laying the groundwork for care that is as tailored to individual needs as possible for all patients.

The partnership between the SCI and the Philas Foundation is intended to help advance this issue in oncology on an ongoing and long-term basis. Together, we aim to raise awareness of gender-specific medicine, promote professional exchange, and help improve equal opportunities across all genders. In the long term, this is intended to support more precise care and contribute to better treatment and quality of life for people with cancer.

We would like to thank the Philas Foundation for its trust and support. We look forward to this long-term partnership and to working together to drive important advancements in gender-specific medicine in oncology and to enable sustainable progress for patients.